0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Plasma Fractionation Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Plasma Fractionation Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Plasma Fractionation Market: By Product Type (Albumin, Immunoglobulin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Fractionation Products), By Application (Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology and Others), By End Users (Hospitals, Clinics, Academic Institutes and Clinical Research Laboratories) and Geography  

 

 

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:
Report

Description

Plasma Fractionation Market size is expected to be valued at USD 26,842.9 million in 2021 and is expected to grow at a CAGR of 6.8% during the forecast period 2022 to 2028. The global market provides a detailed overview and that can be segmented by product type, by application, and by end user. By product type, the global plasma fractionation market has been segmented into Albumin, Immunoglobulin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Fractionation Products. The Immunoglobulin segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. It is attributed to the various off level indications and various applications. The growing prevalence of infections and disorder are boosting the market growth in this segment at a significant rate. The Albumin segment is also growing at a significant rate in 2022 and is expected to maintain the growth in the forecasted years. Based on application, the global plasma fractionation market is segmented into Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology and Others. Among these, the Neurology segment is expected to have the fastest-growing market during the forecast period 2022-2028 according to precision business insights. It is attributed to the faster response of this drug in human body. Based on end user, the global plasma fractionation market is segmented into Hospitals, Clinics, Academic Institutes and Clinical Research Laboratories. The Hospitals segment accounts for the largest share in 2021 and is anticipated to register a significant CAGR in the upcoming years. It is due to the large patient base in the hospitals and various treatments and therapies are available in the hospitals.

Key Development:

In Aug 2022, CSL Plasma reimagines donor experience with first donations completed on innovative plasma collection technology.

In May 2022, CSL Behring’s Biologics License got approval from FDA for Etranacogene Dezaparvovec for Priority Review.

 

Plasma Fractionation Market

MARKET SUMMARY
-
6.8% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 6.8%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Plasma Fractionation Market

  • The report on global plasma fractionation market gives historical, current and future market sizes (US$ Bn) based on product type, by application, end users and geographic regions.
  • plasma fractionation market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Grifols S.A
  • CSL Ltd.
  • Biotest AG
  • LFB S.A
  • Sanquin
Plasma Fractionation Market Drivers

Growing incidence of immune and bleeding disorders, increase in the use of alpha-1 antitrypsin and immunoglobulin, rise in prevalence of Alpha-1 Antitrypsin Deficiency (AATD), emphysema, and haemophilia are anticipated to propel the market growth over the forecast years.

North-America Got Significant Share

Plasma Fractionation Market

North America is expected to witness the highest market share during the forecast period it holds a tremendous potential market for global plasma fractionation.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Features of the Report

  • The report provides granular level information about the market size, regional market share and forecast from 2022-2028
  • The report covers in-detail insights about the competitor’s overview, key findings and their key strategies
  • The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
  • The report tracks recent innovations, key developments and startup’s details that are working in the industry
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenari
Plasma Fractionation Market Segmentation

segmentation-block-image

By Product Type

    • Albumin
    • Immunoglobulin
    • Coagulation Factor Concentrates
    • Protease Inhibitors
    • Other Plasma Fractionation Products
segmentation-block-image

By Application

    • Neurology
    • Haematology
    • Immunology
    • Rheumatology
    • Haemato-oncology
    • Critical Care
    • Pulmonology
    • Others
segmentation-block-image

By End User

    • Hospitals
    • Clinics
    • Academic Institutes
    • Clinical Research Laboratories
Location

GEOGRAPHY

Frequently Asked Questions

The fastest-growing segment of the global plasma fractionation market is Immunoglobulin due to its various applications.

 

 

 

 

 

Rising prevalence of bleeding disorders will create lucrative opportunity in the global market due to major applications of plasma fractionation products.

Collaborations and new product launches and investment in R&D sector are the main strategies of the global players to establish in the market.

Decreasing supply of plasma due to low donor turnout may hamper the global market growth at a significant rate.

Report

Table Of Content

1. Executive summary

2. Global Plasma Fractionation Market Introduction

      2.1. Global Plasma Fractionation Market – Taxonomy
      2.2. Global Plasma Fractionation Market – Definitions
            2.2.1. Product Type

            2.2.2. End User

3. Global Plasma Fractionation Market Dynamics

      3.1. Drivers
      3.2. Restraints
      3.3. Opportunities/Unmet Needs of the Market
      3.4. Trends
      3.5. Global Plasma Fractionation Market Dynamics – Factors Impact Analysis
      3.6. Global Plasma Fractionation Market– Regulations
            3.6.1. U.S
            3.6.2. Europe

            3.6.3. Japan

4. Global Plasma Fractionation Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

      4.3. Market Oppurtunity Analysis

5. Global Plasma Fractionation Market, By Product Type, 2015 – 2019 and Forecast, 2020 – 2026

      5.1. Albumin
            5.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.1.3. Market Opportunity Analysis
      5.2. Immunoglobulins
            5.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.2.3. Market Opportunity Analysis
      5.3. Coagulation factor concentrates
            5.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.3.3. Market Opportunity Analysis
      5.4. Protease inhibitors
            5.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            5.4.3. Market Opportunity Analysis
      5.5. Other Plasma Fractionation Products
            5.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

            5.5.3. Market Opportunity Analysis

6. Global Plasma Fractionation Market Forecast, By Application, 2015 – 2019 and Forecast, 2020 – 2026

      6.1. Neurology
            6.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.1.3. Market Opportunity Analysis
      6.2. Hematology
            6.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.2.3. Market Opportunity Analysis
      6.3. Immunology
            6.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.3.3. Market Opportunity Analysis
      6.4. Rheumatology
            6.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.4.3. Market Opportunity Analysis
      6.5. Haemato-oncology
            6.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.5.3. Market Opportunity Analysis
      6.6. Critical Care
            6.6.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.6.3. Market Opportunity Analysis
      6.7. Pulmonology
            6.7.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            6.7.3. Market Opportunity Analysis
      6.8. Others
            6.8.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

            6.8.3. Market Opportunity Analysis

7. Global Plasma Fractionation Market Forecast, By End user, 2015 – 2019 and Forecast, 2020 – 2026

      7.1. Hospitals
            7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.1.3. Market Opportunity Analysis
      7.2. Clinics
            7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.2.3. Market Opportunity Analysis
      7.3. Academic Institutes
            7.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            7.3.3. Market Opportunity Analysis
      7.4. Clinical Research Laboratories
            7.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

            7.4.3. Market Opportunity Analysis

8. Global Plasma Fractionation Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026

      8.1. North America
            8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.1.3. Market Opportunity Analysis
      8.2. Europe
            8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.2.3. Market Opportunity Analysis
      8.3. Asia-Pacific
            8.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.3.3. Market Opportunity Analysis
      8.4. Latin America
            8.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.4.3. Market Opportunity Analysis
      8.5. Middle East and Africa
            8.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
            8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            8.5.3. Market Opportunity Analysis

      8.6. Global Plasma Fractionation Market- Opportunity Analysis Index – By Product Type, By Application, By End user, and Region, 2020 – 2026

9. North America Plasma Fractionation Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      9.1. Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            9.1.1. Albumin
            9.1.2. Immunoglobulin
                    9.1.2.1. Intravenous immunoglobulin
                    9.1.2.2. Subcutaneous immunoglobulin
                    9.1.2.3. Others
            9.1.3. Coagulation Factor Concentrates
                    9.1.3.1. Factor viii
                    9.1.3.2. Factor ix
                    9.1.3.3. Factor xiii
                    9.1.3.4. Prothrombin complex concentrates
                    9.1.3.5. Von Willebrand factor (VWF)
            9.1.4. Protease Inhibitors
            9.1.5. Other Plasma Fractionation Products
      9.2. Application Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.2.1. Neurology
            9.2.2. Hematology
            9.2.3. Immunology
            9.2.4. Rheumatology
            9.2.5. Haemato-oncology
            9.2.6. Critical Care
            9.2.7. Pulmonology
            9.2.8. Others
      9.3. End user Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            9.3.1. Hospitals
            9.3.2. Clinics
            9.3.3. Academic Institutes
            9.3.4. Clinical Research Laboratories
      9.4. Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
            9.4.1. U.S.
            9.4.2. Canada
      9.5. North America Plasma Fractionation Market- Opportunity Analysis Index – By Product Type, By Application, By End user, and Country, 2020 – 2026

      9.6. North America Plasma Fractionation Market Dynamics – Trends

10. Europe Plasma Fractionation Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      10.1. Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            10.1.1. Albumin
            10.1.2. Immunoglobulin
                    10.1.2.1. Intravenous immunoglobulin
                    10.1.2.2. Subcutaneous immunoglobulin
                    10.1.2.3. Others
            10.1.3. Coagulation Factor Concentrates
                    10.1.3.1. Factor viii
                    10.1.3.2. Factor ix
                    10.1.3.3. Factor xiii
                    10.1.3.4. Prothrombin complex concentrates
                    10.1.3.5. Von Willebrand factor (VWF)
            10.1.4. Protease Inhibitors
            10.1.5. Other Plasma Fractionation Products
      10.2. Application Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.2.1. Neurology
            10.2.2. Hematology
            10.2.3. Immunology
            10.2.4. Rheumatology
            10.2.5. Haemato-oncology
            10.2.6. Critical Care
            10.2.7. Pulmonology
            10.2.8. Others
      10.3. End user Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.3.1. Hospitals
            10.3.2. Clinics
            10.3.3. Academic Institutes
            10.3.4. Clinical Research Laboratories
      10.4. Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            10.4.1. Germany
            10.4.2. UK
            10.4.3. France
            10.4.4. Spain
            10.4.5. Italy
            10.4.6. Russia
            10.4.7. Poland
            10.4.8. Rest of Europe
      10.5. Europe Plasma Fractionation Market- Opportunity Analysis Index – By Product Type, By Application, By End user Type, and Country, 2020 – 2026

      10.6. Europe Plasma Fractionation Market Dynamics – Trends

11. Asia-Pacific Plasma Fractionation Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      11.1. Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            11.1.1. Albumin
            11.1.2. Immunoglobulin
                    11.1.2.1. Intravenous immunoglobulin
                    11.1.2.2. Subcutaneous immunoglobulin
                    11.1.2.3. Others
            11.1.3. Coagulation Factor Concentrates
                    11.1.3.1. Factor viii
                    11.1.3.2. Factor ix
                    11.1.3.3. Factor xiii
                    11.1.3.4. Prothrombin complex concentrates
                    11.1.3.5. Von Willebrand factor (VWF)
            11.1.4. Protease Inhibitors
            11.1.5. Other Plasma Fractionation Products
      11.2. Application Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.2.1. Neurology
            11.2.2. Hematology
            11.2.3. Immunology
            11.2.4. Rheumatology
            11.2.5. Haemato-oncology
            11.2.6. Critical Care
            11.2.7. Pulmonology
            11.2.8. Others
      11.3. End user Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            11.3.1. Hospitals
            11.3.2. Clinics
            11.3.3. Academic Institutes
            11.3.4. Clinical Research Laboratories
      11.4. Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            11.4.1. Japan
            11.4.2. China
            11.4.3. India
            11.4.4. ASEAN
            11.4.5. Australia & New Zealand
            11.4.6. Rest of Asia-Pacific
      11.5. Asia-Pacific Plasma Fractionation Market- Opportunity Analysis Index – By Product Type, By Application, By End user Type, and Country, 2020 – 2026

      11.6. Asia-Pacific Plasma Fractionation Market Dynamics – Trends

12. Latin America Plasma Fractionation Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      12.1. Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            12.1.1. Albumin
            12.1.2. Immunoglobulin
                    12.1.2.1. Intravenous immunoglobulin
                    12.1.2.2. Subcutaneous immunoglobulin
                    12.1.2.3. Others
            12.1.3. Coagulation Factor Concentrates
                    12.1.3.1. Factor viii
                    12.1.3.2. Factor ix
                    12.1.3.3. Factor xiii
                    12.1.3.4. Prothrombin complex concentrates
                    12.1.3.5. Von Willebrand factor (VWF)
            12.1.4. Protease Inhibitors
            12.1.5. Other Plasma Fractionation Products
      12.2. Application Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.2.1. Neurology
            12.2.2. Hematology
            12.2.3. Immunology
            12.2.4. Rheumatology
            12.2.5. Haemato-oncology
            12.2.6. Critical Care
            12.2.7. Pulmonology
            12.2.8. Others
      12.3. End user Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.3.1. Hospitals
            12.3.2. Clinics
            12.3.3. Academic Institutes
            12.3.4. Clinical Research Laboratories
      12.4. Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            12.4.1. Brazil
            12.4.2. Mexico
            12.4.3. Argentina
            12.4.4. Venezuela
            12.4.5. Rest of Latin America
      12.5. Latin America Plasma Fractionation Market- Opportunity Analysis Index – By Product Type, By Application, By End user Type, and Country, 2020 – 2026

      12.6. Latin America Plasma Fractionation Market Dynamics – Trends

13. Middle East & Africa Plasma Fractionation Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026

      13.1. Product Type Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            13.1.1. Albumin
            13.1.2. Immunoglobulin
                    13.1.2.1. Intravenous immunoglobulin
                    13.1.2.2. Subcutaneous immunoglobulin
                    13.1.2.3. Others
            13.1.3. Coagulation Factor Concentrates
                    13.1.3.1. Factor viii
                    13.1.3.2. Factor ix
                    13.1.3.3. Factor xiii
                    13.1.3.4. Prothrombin complex concentrates
                    13.1.3.5. Von Willebrand factor (VWF)
            13.1.4. Protease Inhibitors
            13.1.5. Other Plasma Fractionation Products
      13.2. Application Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            13.2.1. Neurology
            13.2.2. Hematology
            13.2.3. Immunology
            13.2.4. Rheumatology
            13.2.5. Haemato-oncology
            13.2.6. Critical Care
            13.2.7. Pulmonology
            13.2.8. Others
      13.3. End user Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
            13.3.1. Hospitals
            13.3.2. Clinics
            13.3.3. Academic Institutes
            13.3.4. Clinical Research Laboratories
      13.4. Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
            13.4.1. Gulf Cooperation Council (GCC) Countries
            13.4.2. Israel
            13.4.3. South Africa
            13.4.4. Rest of MEA
      13.5. MEA Plasma Fractionation Market- Opportunity Analysis Index – By Product Type, By Application, By End user, and Country, 2020 – 2026

      13.6. MEA Plasma Fractionation Market Dynamics – Trends

14. Competition Landscape

      14.1. Strategic Dashboard of Top Market Players
      14.2. Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
            14.2.1. Grifols S.A (Spain)
            14.2.2. CSL Ltd. (Australia)
            14.2.3. Shire (Ireland)
            14.2.4. Octapharma AG (Switzerland)
            14.2.5. Kedrion S.p.A (Italy)
            14.2.6. China Biologic Products, Inc. (China)
            14.2.7. Biotest AG (OGEL GmbH) (Germany)
            14.2.8. LFB S.A (France)

            14.2.9. Sanquin (Netherlands)

15. Research Methodology

16. Key Assumptions and Acronyms

Report

Company Profile

  • Grifols S.A (Spain)
  • CSL Ltd. (Australia)
  • Shire (Ireland
  • Octapharma AG (Switzerland)
  • Kedrion S.p.A (Italy)
  • China Biologic Products, Inc. (China)
  • Biotest AG (OGEL GmbH) (Germany)
  • LFB S.A (France)
  • Sanquin (Netherlands)

Description

Plasma Fractionation Market size is expected to be valued at USD 26,842.9 million in 2021 and is expected to grow at a CAGR of 6.8% during the forecast period 2022 to 2028. The global market provides a detailed overview and that can be segmented by product type, by application, and by end user. By product type, the global plasma fractionation market has been segmented into Albumin, Immunoglobulin, Coagulation Factor Concentrates, Protease Inhibitors and Other Plasma Fractionation Products. The Immunoglobulin segment is likely to be the largest and fastest-growing segment in terms of type in 2021 and is expected to maintain the trend in the forecasted years. It is attributed to the various off level indications and various applications. The growing prevalence of infections and disorder are boosting the market growth in this segment at a significant rate. The Albumin segment is also growing at a significant rate in 2022 and is expected to maintain the growth in the forecasted years. Based on application, the global plasma fractionation market is segmented into Neurology, Haematology, Immunology, Rheumatology, Haemato-oncology, Critical Care, Pulmonology and Others. Among these, the Neurology segment is expected to have the fastest-growing market during the forecast period 2022-2028 according to precision business insights. It is attributed to the faster response of this drug in human body. Based on end user, the global plasma fractionation market is segmented into Hospitals, Clinics, Academic Institutes and Clinical Research Laboratories. The Hospitals segment accounts for the largest share in 2021 and is anticipated to register a significant CAGR in the upcoming years. It is due to the large patient base in the hospitals and various treatments and therapies are available in the hospitals.

Key Development:

In Aug 2022, CSL Plasma reimagines donor experience with first donations completed on innovative plasma collection technology.

In May 2022, CSL Behring’s Biologics License got approval from FDA for Etranacogene Dezaparvovec for Priority Review.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+